X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (260) 260
Publication (11) 11
Data Set (5) 5
Book / eBook (4) 4
Patent (3) 3
Book Chapter (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (86) 86
index medicus (74) 74
oncology (44) 44
female (35) 35
male (34) 34
hematology (33) 33
immunology (32) 32
middle aged (32) 32
aged (28) 28
cancer (28) 28
adult (27) 27
expression (27) 27
killer cells, natural - immunology (27) 27
leukemia (25) 25
cell line, tumor (22) 22
abridged index medicus (20) 20
activation (20) 20
aged, 80 and over (20) 20
nk cells (20) 20
t-cells (18) 18
ligands (16) 16
natural-killer-cells (16) 16
acute myeloid-leukemia (15) 15
adolescent (15) 15
animals (15) 15
young adult (14) 14
immunotherapy (13) 13
prognosis (13) 13
down-regulation (12) 12
flow cytometry (12) 12
leukemia, myeloid, acute - genetics (12) 12
mice (12) 12
apoptosis (11) 11
tumor-cells (11) 11
killer cells, natural - metabolism (10) 10
research (10) 10
acute myeloid leukemia (9) 9
cytotoxicity (9) 9
metastasis (9) 9
receptor (9) 9
analysis (8) 8
cells, cultured (8) 8
neoplasms - immunology (8) 8
nkg2d (8) 8
cell biology (7) 7
chronic lymphocytic-leukemia (7) 7
cutting edge (7) 7
dendritic cells (7) 7
disease-free survival (7) 7
fas ligand (7) 7
hemic and lymphatic diseases (7) 7
histocompatibility antigens class i - blood (7) 7
in-vivo (7) 7
ligand (7) 7
nk cell lectin-like receptor subfamily k (7) 7
receptors, natural killer cell (7) 7
regulatory t-cells (7) 7
survival (7) 7
t-lymphocytes - immunology (7) 7
treatment outcome (7) 7
aml (6) 6
antigens (6) 6
cancer-immunotherapy (6) 6
cells (6) 6
coculture techniques (6) 6
diagnosis (6) 6
enzyme-linked immunosorbent assay (6) 6
family (6) 6
gene expression regulation, leukemic (6) 6
histocompatibility antigens class i - metabolism (6) 6
interferon-gamma - biosynthesis (6) 6
killer cells, natural - drug effects (6) 6
leukemia - immunology (6) 6
leukemia, myeloid, acute - metabolism (6) 6
medicine & public health (6) 6
mica (6) 6
mutation (6) 6
natural killer cells (6) 6
receptors, immunologic - metabolism (6) 6
signal transduction - immunology (6) 6
4-1bb ligand (5) 5
antineoplastic agents - pharmacology (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
azacitidine - analogs & derivatives (5) 5
biomarkers, tumor - blood (5) 5
cancer research (5) 5
cd137 ligand (5) 5
cell line (5) 5
dasatinib (5) 5
fas ligand protein (5) 5
gene (5) 5
genetics (5) 5
histocompatibility antigens class i - immunology (5) 5
hla (5) 5
immune-responses (5) 5
immunity (5) 5
immunosurveillance (5) 5
in-vitro (5) 5
k562 cells (5) 5
killer cells, natural - pathology (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


EMBO Molecular Medicine, ISSN 1757-4676, 10/2019
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2017, Volume 66, Issue 4, pp. 867 - 868
Journal Article
INTERNATIONAL JOURNAL OF ONCOLOGY, ISSN 1019-6439, 08/2019, Volume 55, Issue 2, pp. 347 - 358
Virotherapy comprises a novel therapeutic approach to selectively eliminate cancer cells. Preclinical, as well as clinical data have demonstrated the efficacy... 
prodrug | CELLS | RNA | RECEPTOR | virotherapy | COMBINATION | chemotherapy | MDA-5 | measles vaccine virus | acute myeloid leukemia | ONCOLOGY | oncolytic virus | CHEMOVIROTHERAPY
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1344 - 1344
Abstract NK cells are lymphoid components of innate immunity and play an important role in tumor immunosurveillance. One of the major transcriptional... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 731 - 731
Abstract Introduction: The efficacy of monoclonal antibodies (mAbs), which have substantially improved treatment options for cancer patients, largely relies on... 
Journal Article
Blood, ISSN 0006-4971, 02/2019, Volume 133, Issue 6, pp. 550 - 565
Antileukemia immunity plays an important role in disease control and maintenance of tyrosine kinase inhibitor (TKI)-free remission in chronic myeloid leukemia... 
CHRONIC MYELOGENOUS LEUKEMIA | HEALTHY DONORS | MIMIC ANTIBODY | WT1 | IMATINIB | RECEPTOR | MOLECULAR RESPONSE | HEMATOLOGY | MASS-SPECTROMETRY | PEPTIDE VACCINE | DISCONTINUATION
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3928 - 3928
Background: Substantial surface expression of the FLT3 receptor can be measured on blast cells in 70% to 100% of acute myeloid leukemia (AML) patients, while... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3173 - 3173
Abstract The B-cell maturation antigen (BCMA) is selectively expressed by cells of the B-lineage, including multiple myeloma (MM) cells, and constitutes a... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5223 - 5223
Abstract In recent years, therapeutic approaches for acute myeloid leukemia (AML) have been improved, however the disease is still characterized by high... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4046 - 4046
Abstract Several studies demonstrated that peptide-based cancer immunotherapy can induce specific immune responses and affect clinical outcome in a variety of... 
Journal Article
Journal for immunotherapy of cancer, ISSN 2051-1426, 05/2019, Volume 7, Issue 1, pp. 143 - 15
Monoclonal antibodies (mAbs) mediate their effects in great part by inducing ADCC of NK cells, and multiple efforts aim to increase this function by... 
Flow cytometry | Usage | Immunotherapy | Proteins | Antigens | Immunoglobulins | Cytokines | Lymphocytes | Leukemia | Melanoma | Cancer therapies | Chromatography | Tumors | AML | CD16 | CD3 | NKG2DL | Bispecific
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2867 - 2867
Abstract Introduction: Time to acute myeloid leukemia (AML) development is not assessable in patients, but a longer time to relapse after apparent remission is... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2558 - 2558
Abstract Monoclonal antibodies (mAbs) have by now become an established tool in therapy of many malignancies. The interaction of a mAb's Fc portion with Fcγ... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2947 - 2947
Abstract Abt-199 is a small molecule BCL-2 inhibitor which has recently been approved for treatment of CLL and mediates its effects by induction of apoptosis... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3793 - 3793
Abstract NK cells largely contribute to the success of monoclonal antibody (mAb) application in cancer due to their ability to mediate antibody-dependent... 
Journal Article
Proceedings of the National Academy of Sciences, USA, ISSN 0027-8424, 11/2016, Volume 113, Issue 48, pp. 13827 - 13827
Graft-versus-host disease (GVHD) represents the major nonrelapse complication of allogeneic hematopoietic cell transplantation. Although rare, the CNS and the... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 2739 - 2739
Abstract CD133 is expressed in various types of solid tumors where it predicts an unfavourable clinical outcome (e.g. Linuma et al., J Clin Oncol. 2011).... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 1722 - 1722
Abstract Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. The course of disease predisposes patients to the development of secondary... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.